TABLE 1.
Descriptive information about included studies
| First author (Year) | Country | Antidepressant(s) | Weeks Treated | N | Time since injury | Severity of injury |
|---|---|---|---|---|---|---|
| Ansari31 (2014) | India | Sertraline | 24 | 80 | >2 wk | Mild and moderate |
| Ashman32 (2009) | USA | Sertraline | 10 | 41 | 17 y | Mild to severe |
| Dinan30 (1992) | Ireland | Amitriptyline | 6 | 13 | 4.8 wk | Mild |
| Fann33 (2000) | USA | Sertraline | 8 | 15 | 10.6 mo | Mild |
| Fann34 (2017) | USA | Sertraline | 12 | 53 | 4.6 mo | Mild to severe |
| Horsfield35 (2002) | USA | Fluoxetine | 35 | 5 | Not reported | Mild |
| Lee26 (2005) | Korea | Methylphenidate and sertraline | 4 | 30 | 32.2 d | Mild to moderate |
| Newburn27 (1999) | New Zealand | Moclobemide | 3 | 26 | 4.67 y | Not reported |
| Rao29 (2013) | USA | Escitalopram | 12 | 14 | Not reported | Not reported |
| Rapoport28 (2008) | Canada | Citalopram | 10 | 54 | <1 y | Mild to severe |
| Saran30 (1985) | USA | Amitriptyline and phenelzine | 156 | 10 | <1 y | Mild |